This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Year of Passing: 2022 & 2023 only. Chemistry/ B.Tech Chemical/ B.Pharm) with good communication skills are highly preferred. Aurobindo Pharma-Openings for Freshers – Project Management -Apply Now.
The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels.
Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceuticalmanufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). Bob is currently Sr.
Suresh Kannan: This latest semi-annual platform update brings innovative revenue optimization and compliance solutions to our high-tech and life sciences customers, including pharmaceuticalmanufacturers. Specifically, our Fall 2022 release helps our pharma customers achieve compliance and meet their strategic objectives quickly.
We believe it would be hard to outline all of our activities in 2022, so we’ll try to focus on the very best things that happened to Viseven this year. In 2022 Viseven finally launched a long-awaited overseas office in the LatAm region, namely in Argentina. Top Events of 2022. New Locations and New Faces.
A recent report from the US Food and Drug Administration (FDA) shows that while the number of new drug shortages has fallen significantly from a high of 250 in 2011 to 49 in 2022, there was an increase in new drug shortages year-on-year. What are the top three supply-related challenges facing pharmaceuticalmanufacturers?
Omnibus Spending Law: Provisions Will Bolster Medicines Supply Chain Insights and Advanced Manufacturing Technologies Investments to create a more resilient medicines supply chain and prepare for future public health emergencies are among key provisions of the mammoth $1.7
That way…we can do our best to communicate with you about how to best prepare a submission.” The audit showed that manufacturers that submitted PCM applications actually “had relatively shorter times to approval and market as compared to similar batch applications…translating to an estimated $171-537M in early revenue benefit.”
Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report. Due to the cessation of Russian gas imports following its invasion of Ukraine, electricity prices increased up to tenfold, and raw material costs rose by 50% to 160% in Q3 2022.
At the start of this year, the World Health Organisation (WHO) said that more than 300 children had died in The Gambia, Indonesia and Uzbekistan in 2022 in deaths linked to contaminated medicine. In this instance of contaminated cough syrups, the concern is around an excipient in the product and not the active pharmaceutical ingredient (API).
in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Koerber-Walker discussed how the Inflation Reduction Act, introduced in 2022 , may benefit biologics companies’ funding plans going into the next year. Certain companies will struggle more than others with accruing investment from venture capital firms.
Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceuticalmanufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.
Despite the current emphasis on biologic medicines, small molecule drugs still dominate the pharmaceuticalmanufacturing world. Within the small molecule landscape, several trends are shaping the industry’s future, one of the most notable being the rise of high-potency active pharmaceutical ingredients (HPAPIs).
In an age of disruption, technology is key to enabling pharmaceuticalmanufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised. To learn more, download the paper below. [i]
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content